Code Biotherapeutics
ID: 7642979Code Biotherapeutics is a DNA-based Gene Therapy Vector founded in 2020 by Brian J. McVeigh, Lori Getts and Robert Getts.
1
Funding Rounds
$75.0m
Money raised
Recent Funding Rounds
Overview
Code Biotherapeutics is a DNA-based Gene Therapy Vector founded in 2020 by Brian J. McVeigh, Lori Getts and Robert Getts.
- Website:
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ro**** Ge*** |
|
- | |
| Br*** J. Mc***** |
|
- | - |
| Lo** Ge*** |
|
- |
Funding series
Funding Series Analysis
The company Code Biotherapeutics has raised a total of $75m in funding over 1 rounds.
Key Insights:
- Code Biotherapeutics Series A round, June 2022: $75m
Industries
Code Biotherapeutics is active in the following industries: